Japanese drugmaker sees opportunities at China import expo

**This is a 60-seconds sample of the video. For the full version, please contact us.**

Japanese drugmaker sees opportunities at China import expo

STORY: Japanese drugmaker sees opportunities at China import expo SHOOTING TIME: Nov. 9, 2023 DATELINE: Nov. 10, 2023 LENGTH: 00:00:49 LOCATION: SHANGHAI, China CATEGORY: ECONOMY SHOTLIST: 1. various of Takeda's exhibits at the sixth CIIE 2. SOUNDBITE (Chinese): SHAN GUOHONG, Senior vice president of Takeda and president of Takeda China STORYLINE: Takeda Pharmaceutical, one of Japan's biggest drugmakers, is a "frequenter" at this year's China International Import Expo (CIIE) in Shanghai. Over the past six years, China has grown to be Takeda's third largest market globally. And the company's Chinese subsidiary has developed into one of the best-performing transnational pharmaceutical firms in China. SOUNDBITE (Chinese): SHAN GUOHONG, Senior vice president of Takeda and president of Takeda China "We are very pleased to be able to participate in the CIIE every year. This platform enables us to swiftly bring our global innovation achievements to China. In the future, we will continue to strengthen our coop

  • Product Code
  • ILEA001970962
  • Registered date
  • 2023/11/10 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • × pixel
  • Deployment size
  • (KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos